New clotting drug may save lives in severe trauma bleeding
NCT ID NCT05738642
First seen Apr 29, 2026 · Last updated May 18, 2026 · Updated 8 times
Summary
This study tested whether giving a clotting factor concentrate (4F-PCC) early to people with severe traumatic bleeding can reduce organ failure and death. About 380 adults with major injuries were enrolled within 3 hours of injury. The goal was to see if this treatment improves survival and reduces the need for blood transfusions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE TRAUMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Yongan Xu
Hangzhou, Zhejiang, 310009, China
Conditions
Explore the condition pages connected to this study.